About Munani Pharmaceuticals
Munani Pharmaceuticals is a Healthcare company based in Mumbai (India) founded in 1999. It operates as an exports and distributes specialty medicines, life-saving drugs globally. It operates on a B2B and Wholesale Distribution model. Its Indian entity Munani Pharmaceuticals Private Limited reported revenue of ₹6.75 Cr. Munani Pharmaceuticals offers products and services including Aztreogem 1gm USP Injection and Pyrigem 5mg/ml 2ml Injection. Its focus areas include Pharmaceuticals, Cardiology, Heart Medications and Nephrology. Its competitors include Cardinal Health, ACG Associated Capsules, Dvijay Pharma, Nu Sri Shyam Pharmaceuticals and Kapbro Pharma and 2 more.
Company details
Munani Pharmaceuticals, established in 1999, is a leading exporter, distributor, and wholesaler of specialty pharmaceutical and healthcare products based in Mumbai, India. They provide value-added services to pharmacists, retailers, hospitals, and distributors worldwide, handling branded medicines and temperature-controlled shipments. With three decades of experience, they focus on fields like oncology, nephrology, and cardiology, offering quality products from multinational companies while adhering to industry standards.
- Headquarters Mumbai, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website munanipharma.com
- Legal Name Munani Pharmaceuticals Pvt Ltd
- Date of Incorporation 12 Jun, 2023
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹6.75 Cr
FY 2025 · +471% YoY
- Net Profit₹20.5 Lakh
FY 2025 · 3% margin
- EBITDA₹42.3 Lakh
FY 2025 · 6% margin
Associated legal entities of Munani Pharmaceuticals
Munani Pharmaceuticals operates through Munani Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Munani Pharmaceuticals Private Limited CIN U46497MH2023PTC404911 | Active | 12 Jun 2023 | Mumbai, Maharashtra | ₹6.8 Cr | – | 4 | View details |
Products & Services of Munani Pharmaceuticals
Munani Pharmaceuticals offers a comprehensive portfolio of products and services, including Aztreogem 1gm USP Injection and Pyrigem 5mg/ml 2ml Injection.
Antibiotic injection for treating bacterial infections.
Medication for cardiovascular conditions and blood flow.
Board of directors of Munani Pharmaceuticals Private Limited (Munani Pharmaceuticals)
Munani Pharmaceuticals Private Limited is the primary company behind Munani Pharmaceuticals. The board of Munani Pharmaceuticals Private Limited currently have 4 directors; the longest-serving is Krutik Arvind Munani, appointed in 2023.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Krutik Arvind Munani DIN 09403633 | Managing Director | 12 Jun 2023 | 3 yrs 4 mo | Munani Pharmaceuticals Private Limited |
| Priyanshi Krutik Munani DIN 09403634 | Managing Director | 12 Jun 2023 | 3 yrs 4 mo | Munani Pharmaceuticals Private Limited |
| Sarojben Arvindkumar Munani DIN 10203308 | Director | 12 Jun 2023 | 3 yrs 4 mo | Munani Pharmaceuticals Private Limited |
| Arvindkumar Jawaji Munani DIN 10203309 | Director | 12 Jun 2023 | 3 yrs 4 mo | Munani Pharmaceuticals Private Limited |
Financials of Munani Pharmaceuticals
Figures of Munani Pharmaceuticals Private Limited, the primary company behind Munani Pharmaceuticals, for FY 2025. Revenue was ₹6.75 Cr (+471% year on year). Net profit was ₹20.5 Lakh (3% margin). EBITDA was ₹42.3 Lakh (6% margin).
- ₹6.75 CrRevenue · FY 2025 · +471% YoY
- ₹20.5 LakhNet profit · 3% margin
- ₹42.3 LakhEBITDA · 6% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Munani Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Munani Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Munani Pharmaceuticals
Munani Pharmaceuticals has 7 listed competitors in our database. They include Cardinal Health, ACG Associated Capsules, Dvijay Pharma, Nu Sri Shyam Pharmaceuticals and Kapbro Pharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cardinalhealth.com | 1971 | Dublin, United States | – | 48,900 | Multiple healthcare products and services are provided to organizations. | |
| associatedcapsules.com | 1961 | Mumbai, India | – | 1,444 | A distributor specializing in gelatin capsules for pharmaceutical applications. | |
| dvijaypharma.com | 1975 | Nashik, India | – | 68 | Serves as a distributor of specialty drugs. | |
| nsspharma.com | 2013 | Kolkata, India | – | 58 | Distributes anti-HIV, life-saving, and anti-cancer medicines to hospitals and patients. | |
| kapbropharma.com | 2018 | Delhi, India | – | 26 | Distributes super-speciality and general pharmaceuticals to chemists, hospitals, and patients. | |
| shivshivampharma.com | 1989 | Kolkata, India | – | 18 | Distributor and retailer of oncology medicines with partnerships in healthcare. | |
| shreejiimaging.com | 1990 | Mumbai, India | – | – | Manufactures PET radiotracers for cancer detection and disease management. |
Detailed competitors of Munani Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as Munani Pharmaceuticals (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Munani Pharmaceuticals
Munani Pharmaceuticals was founded in 1999.
Munani Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Munani Pharmaceuticals, Munani Pharmaceuticals Private Limited, reported revenue of ₹6.75 Cr for FY 2025, up 471% year on year.
Munani Pharmaceuticals, established in 1999, is a leading exporter, distributor, and wholesaler of specialty pharmaceutical and healthcare products based in Mumbai, India. They provide value-added services to pharmacists, retailers, hospitals, and distributors worldwide, handling branded medicines and temperature-controlled shipments. With three decades of experience, they focus on fields like oncology, nephrology, and cardiology, offering quality products from multinational companies while adhering to industry standards.
Munani Pharmaceuticals's top competitors include Cardinal Health, Dvijay Pharma and ACG Associated Capsules.
Munani Pharmaceuticals offers Aztreogem 1gm USP Injection and Pyrigem 5mg/ml 2ml Injection.
Munani Pharmaceuticals operates through Munani Pharmaceuticals Private Limited.
The legal entities of Munani Pharmaceuticals currently have 4 directors, including Krutik Arvind Munani, Priyanshi Krutik Munani, Sarojben Arvindkumar Munani and others.